Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2643CTIDB
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatobiliary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Hepatobiliary Disease 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 12

Clinical Trials by Phase in G7 Countries 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Unaccomplished Trials of Hepatobiliary Disease 19

Subjects Recruited Over a Period of Time 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Prominent Drugs 23

Clinical Trial Profiles 24

Clinical Trial Overview of Top Companies 24

Pfizer Inc. 24

Clinical Trial Overview of Pfizer Inc. 24

Clinical Trial Overview of Top Institutes / Government 25

Hiroshima University Hospital 25

Clinical Trial Overview of Hiroshima University Hospital 25

Hokkaido University Hospital 26

Clinical Trial Overview of Hokkaido University Hospital 26

Osaka University 27

Clinical Trial Overview of Osaka University 27

The University of Tokyo 28

Clinical Trial Overview of The University of Tokyo 28

Chiba University 29

Clinical Trial Overview of Chiba University 29

Guangdong Science and Technology Department 30

Clinical Trial Overview of Guangdong Science and Technology Department 30

Haydarpasa Numune State Hospital 31

Clinical Trial Overview of Haydarpasa Numune State Hospital 31

Hokkaido University School of Medicine 32

Clinical Trial Overview of Hokkaido University School of Medicine 32

Japanese Endoscopist & IVRists group for Biliary Tract Cancer 33

Clinical Trial Overview of Japanese Endoscopist & IVRists group for Biliary Tract Cancer 33

Kyoto Prefectural University of Medicine 34

Clinical Trial Overview of Kyoto Prefectural University of Medicine 34

Five Key Clinical Profiles 35

Appendix 49

Abbreviations 49

Definitions 49

Research Methodology 50

Secondary Research 50

About GlobalData 51

Contact Us 51

Disclaimer 51

Source 51

List of Figures

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

GlobalData Methodology 50

List of Tables

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6

Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19

Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 19

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 24

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 25

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015* 26

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 27

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 28

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 29

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015* 30

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015* 31

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015* 32

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist & IVRists group for Biliary Tract Cancer, 2015* 33

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Hepatobiliary Disease Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatobiliary Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162350
Site License
USD 5000 INR 324700
Corporate User License
USD 7500 INR 487050

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com